Context Therapeutics Announces Acceptance of Abstract to be Presented at the Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting

PHILADELPHIA, Sept. 27, 2023 -- Context Therapeutics Inc. , a biopharmaceutical company advancing medicines for solid tumors, today announced a poster regarding the Company’s preclinical asset,...

Related Keywords

San Diego Convention Center ,California ,United States ,San Diego ,Philadelphia ,Pennsylvania ,Gina Cestari ,Joseph Rucker ,Jennifer Minai Azary ,Linkedin ,Exchange Commission ,Society For Immunotherapy Of Cancer ,Twitter ,Context Therapeutics Inc ,Company Nasdaq ,Nasdaq ,Annual Meeting ,Exhibit Halls ,San Diego Convention ,Private Securities Litigation Reform Act ,Relations Contact ,Markets ,